| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0e02697135dade4ea39346afd1fe43d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-625 |
| filingDate |
2008-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_086e2eb5d9d0354efe7c6b93787b5244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c140a524b55b2b210c524d00587a4844 |
| publicationDate |
2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103936756-A |
| titleOfInvention |
New compound having anti-blood coagulation effect |
| abstract |
The invention discloses a compound represented by a general formula (1) or a salt or a stereoisomer and a preparation method thereof, and a medicinal combination at least comprising at least one compound represented by the general formula (1) or the salt or the stereoisomer thereof as an active ingredient, wherein R1, R2 and R3 are defined in the specification. The compound has the function of inhibition of platelet aggregation, and is used for prevention and treatment of thrombus or embolism disease. |
| priorityDate |
2008-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |